medigraphic.com
ISSN 0185-6014 (Impreso)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2015, Número 3

<< Anterior Siguiente >>

Rev Mex Patol Clin Med Lab 2015; 62 (3)


Aspectos actuales de las infecciones emergentes y reemergentes

Barriga AG, Hernández SEA

Idioma: Español
Referencias bibliográficas: 62
Paginas: 174-182
Archivo PDF: 246.78 Kb.


RESUMEN

Durante las últimas cuatro décadas, han emergido 62 nuevos agentes infecciosos y han reemergido 14, dando lugar a la aparición de numerosos brotes epidémicos e, incluso, dos pandemias, con un elevado costo en vidas humanas y económicas. Este fenómeno se debe a los cambios ambientales, climáticos, ecológicos y sociales derivados de la explosión demográfica humana, que en este momento sobrepasa los 7 mil millones. Esto no es nuevo y a través de la historia del ser humano se han producido tres transiciones previas que han dado lugar a la emergencia y reemergencia de enfermedades infecciosas; en este artículo son analizadas en un concepto histórico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Van Doom HR. Emerging infectious diseases. Medicine (Abingdon). 2014; 42 (1): 60-63.

  2. McMichael AJ. Environmental and social influences on emerging infectious diseases: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2004; 359: 1049-1058.

  3. Morens MD, Fauci SA. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog. 2013; 9 (7): 1-3.

  4. Nichol ST, Arikawa J, Kawaoka Y. Emerging viral diseases. Proc Natl Acad Sci U S A. 2000; 97 (23): 12411-12412.

  5. Woolhouse MEJ, Sequeira GS. Host range and emerging and reemerging pathogens. Emerg Infect Dis. 2004; 11 (12): 1842-1847.

  6. Pearce-Duvet JM. The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease. Biol Rev Camb Philos Soc. 2006; 81: 369-382.

  7. Isreal DM. Early human settlements as an opportunity for infectious microorganisms. J Biosci. 2005; 30 (4): 411-414.

  8. Spekker O, Pálfi G, Kozocsay G, Posa A, Pereczki Z, Molnar E. New cases of probable skeletal tuberculosis from the neolitic period in Hungary. A morphological study. Acta Biologica Saegediensis. 2012; 56 (2): 115-123.

  9. Stinginska BB, Druzecyriska MJ, Lerkiiewice N, Szewczyk R, Zadzins­­ka E. Mycolic acid as marker of osseous tuberculosis in two neolitic skeletons from Kujawy region (Central Poland). Anthropological Review. 2014; 77 (2):137-149.

  10. Comas I, Coscolla M, Luo T, Borrell S, Holt HE, Maeda KM et al. Out of Africa migration and neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet. 2013; 45: 1176-1182.

  11. Wiechmann I, Grupe G. Detection of Yersinia pestis DNA in two early medieval skeletal finds from Aschheim (Upper Bavaria, 6th century AD). Am J Phys Anthropol. 2005; 126 (1): 48-55.

  12. Harbeck M, Seifert I, Hansch S, Wagner DM, Sindsell P. Yersinia pestis DNA from skeletal remains from the 6th Century AD reveals insights into Justinian plague. PLoS Pathog. 2013; 9 (5): e1003349.

  13. Trevisanato SI. The biblical plague of the Philistines now has a name, tularemia. Med Hypotheses. 2007; 69: 1144-1146.

  14. Morabia A. Epidemic and population patterns in the Chinese Empire (243 B.C.E. to 1911 C.E.): quantitative analysis of a unique but neglected epidemic catalogue. Epidemiol Infect. 2009; 137: 1361-1368.

  15. Trevisanato SI. The Hittite plague and epidemic of tularemia and the first record of biological warfare. Med Hypotheses. 2007; 69 (6): 1371-1374.

  16. Trevisanato SI. Did and epidemic of tularemia in ancient Egypt affect the course of world history? Med Hypotheses. 2004; 63: 905-910.

  17. Trevisanato SI. Ancient Egyptian doctors and the nature of the biblical plagues. Med Hypotheses. 2005; 65: 811-813.

  18. Dagnino JS. ¿Qué fue la plaga de Atenas? Rev Chil Infect. 2011; 28 (4): 374-378.

  19. Muñoz SA. Marcus Aurelius Antonius (121-181AD) philosopher and Roman emperor and Galen’s plague. Enferm Infecc Microbiol Clin. 2012; 30 (9): 552-559.

  20. Sabbatani S, Fiorino S. The Antonine plague and the decline of the Roman empire. Infez Med. 2009; 17 (4): 261-275.

  21. Ligon BL. Plague: a review of its history and potential as a biological weapon. Semin Pediatr Infect Dis. 2006; 17: 161-170.

  22. Darling NI, Donoghue HD. Insights from paleomicrobiology into the indigenous people of pre-colonial America. A review. Mem Inst Oswaldo Cruz. 2014; 109 (2): 1-11.

  23. Diomedi AP. La guerra biológica en la conquista del Nuevo Mundo. Una revisión histórica y sistemática de la literatura. Rev Chil Infect. 2003; 20 (1): 19-25.

  24. Acuña SR, Romero LC, Maguire JH. Large epidemics of hemorrhagic fevers in Mexico 1545-1815. Am J Trop Med Hyg. 2000; 62 (6): 733-739.

  25. Acuña SR, Stahle DW, Therrell MD, Griffin RD, Cleaveland MK. When half of population died: the epidemic of hemorrhagic fevers of 1576 in Mexico. FEMS Microbiol Lett. 2004; 240 (1): 1-15.

  26. Acuña SR, Sthale DW, Cleaveland M, Therrel M. Megadrought and megadeath in the 16 century in Mexico. Emerg Infec Dis. 2002; 8 (4): 360-362.

  27. Favila CH. Entre ceros, lagos y ciénegas. Sociedad y condiciones de salud en el México prehispánico. Ciencia. 2014; 20 (3): 182-192.

  28. Cordero CM. Las grandes epidemias en la América colonial. Arch Zootec. 2001; 50: 697-612.

  29. Mckenna VG, Meadow JA, Brewer NS, William WR, Perrault J. Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases. Mayo Clinic Proceedings. 1980; 55 (11): 663-672.

  30. Barrera CA, Díaz KRD, Viniegra OA, Grajales MC, Dávila TJ. Lineamientos técnicos para la prevención y tratamiento de la fiebre Chikunguña. Rev Med Inst Mex Seg Soc. 2015; 53 (1): 402-419.

  31. Atergard EP, Brown KE. Human parvovirus B-19. Clin Microbiol Rev. 2002; 15 (3): 485-505.

  32. Tzipori S, Widmar GA. Hundred year retrospective on cryptosporidiosis. Trends Parasitol. 2008; 24 (4): 184-189.

  33. Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009; 15 (9): 1347-1350.

  34. Staples E, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review. Emerg Infect Dis. 2009; 4 (6): 924-942.

  35. Calisher CH, Childs JE, Field HE, Holmas KV, Schountz T. Bats: important reservoir hosts of emerging viruses.Clin Microbiol Rev. 2006; 19 (3): 531-545.

  36. Khan A, Khan AS. Hantaviruses: a tale of two hemispheres. Panminerva Med. 2008; 45 (1): 43-54.

  37. Centers for Disease Control and Prevention (CDC). Update: multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio and Wisconsin. MMWR Morb Mortal Wkly Rep. 2003; 52 (27): 642-646.

  38. Aguzzi A, Heikenwalder M. Pathogenesis of prion diseases, current status and future outlook. Nat Rev Microbiol. 2006; 4: 765-775.

  39. Gallo RC. The discovery of the first human retrovirus HTLV-1 and HTLV-2. Retrovirology. 2005; 2: 17.

  40. Kapikian AZ, Wyatt RG, Dalin R, Thornhill TS, Kalica A, Chanock RM. Visualization by immune electron microscopy of a 27 nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol. 1972; 10 (5): 1075-1081.

  41. Mac Kenzie WE. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med. 1994; 19 (331): 161-167.

  42. Campbell GL, Hughes JM. Plague in India. A new emerging form and old nemesis. Annals Intern Med. 1995; 122 (2): 151-153.

  43. Steere AC, Malawista SE, Snydman AA. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1997; 20 (1): 7-17.

  44. Duffy MA, Chen F, Hancock WT, Powers AM, Kool JL, Lanciotti ES. Zika virus outbreak on Yap Islands Federated States of Micronesia. N Engl J Med. 2009; 360: 2536-2543.

  45. Retief F, Cilliers L. Measles in antiquity and the Middle Ages. S Afr Med J. 2010; 100 (4): 216-217.

  46. Levy S. The evolution of tuberculosis. Genetic analysis offers new insights on the spread of an ancient disease. Bioscience. 2012; 62 (7): 625-629.

  47. Kahn JS. Epidemiology of human metapneumovirus. Clin Microbiol Rev. 2006; 19 (3): 548-557.

  48. Jay TM, Glaser C, Fulhorst CF. The arenaviruses. J Am Vet Med Assoc. 2005; 227 (6): 904-915.

  49. Paddock CD, Childs JE. Ehrlichia chaffeensis: a prototypical emer­ging pathogen. Clin Microbio Rev. 2003; 18 (1): 37-64.

  50. Gessain A, Rua R, Betsem E, Tupin J, Mahieux R. HTLV3/4 and simian foamy retrovirus in humans: discovery, epidemiology, cross-species transmission and molecular virology. Virology. 2013; 435: 187-194.

  51. Cossart YE, Field AM, Cont S, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975; 1: 72-73.

  52. Field H, Schaaf K, Kung N, Simon C, Waltisbuhl D, Hobert H et al. Hendra virus outbreak with novel clinical features, Australia. Emerg Infect Dis. 2010; 16 (2): 338-340.

  53. Akntar A, Bulkada E, Basu P, Kunar P. Exposing the origins of the Ebola outbreak. Urging for a shift in the response from reactive to active. American J Infect Dis Microbiol. 2014; 2 (611): 1-18.

  54. Wolfe DN. Bushmeat hunting, deforestation and prediction of zoonotic disease emergence. Emerg Infect Dis. 2005; 11 (12): 1822-1827.

  55. Vliet N, Mesa QMD, Antia CD, Aquino AL, Moreno J, Nasi P. The uncovered volumes of bus meat commercialized in the Amazonian tri frontier between Colombia, Peru and Brazil. Ethnobiology Conservation. 2014; 3 (7): 1-11.

  56. Briand S, Bertherat E, Cox P, Formenty P, Kieny MP, Myhre JK et al. The international Ebola emergency. New Engl J Med. 2014; 371 (13): 1180-1183.

  57. Daszak D, Cunninghan AA, Hyatt AD. Emerging infectious diseases of wildlife threats to biodiversity and human health. Science. 2000; 287 (21): 443-449.

  58. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD et al. Update of avian infection A (H5N1), virus infection in humans. N Engl J Med. 2008; 58: 261-273.

  59. Dawood FS, Juliano HA. Estimated global mortality association with the first 12 months of 2009 of pandemic influenza. A H1N1 virus circulation a modeling study. Lancet Infect Dis. 2012; 12 (4): 687-695.

  60. Bowman KS, Nelson SW, Page SL, Nolting JM, Killian NL, Sreevatsan S et al. Swine to human transmission of influenza A(H3N2) virus at agricultural fairs, Ohio USA, 2012. Emerg Infect Dis. 2014; 20 (9): 1472-1480.

  61. Zhang Y, Yu YS, Tang ZT, Chan XH, Zang CQ. Human infection with avian influenza A(H7N9) virus. Rev Inst Med Trop Sao Paulo. 2014; 56 (4): 367-368.

  62. Lin YP, Shaw M, Cameron K, Lim W, Kliman A et al. Avian to human transmission of H9N2 and H5N1 human isolates. PNAS. 2000; 97 (17): 9654-9658.




2020     |     www.medigraphic.com